^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

anzutresgene autoleucel (IMA203)

i
Other names: IMA-203, IMA 203, anzu-cel, IMA203, autologous TCR-engineered T cells, ACTengine IMA203, IMA 2013, IMA203 T-cell product, IMA2013, IMA-2013
Associations
Trials
Company:
Immatics
Drug class:
PRAME inhibitor
Associations
Trials